HSPB1 and alkaline phosphatase measurement: Notably, concurrent inhibition of apoptosis and ferroptosis by Hspb1 has been shown to mitigate acinar cell damage and prevent severe AP progression, underscoring the therapeutic potential of dual-targeting PCD pathways (He et al., 2024).